ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 16,700 shares, a growth of 12.1% from the January 15th total of 14,900 shares. Based on an average daily trading volume, of 18,300 shares, the days-to-cover ratio is currently 0.9 days.
普魯超股納斯達克生物科技 (NASDAQ: BIS — 獲得評級) 在一月份短期利益顯著增長的接收者.截至 1 月 31 日，短期利息總額為 16,700 股，較 1 月 15 日共 14,900 股股份增長 12.1%。根據 18,300 股的平均每日交易量計算，日數佔覆蓋率目前為 0.9 天。
Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology
機構投資者權衡保證超低納斯達克生物科技
A number of institutional investors have recently added to or reduced their stakes in the company. IMC Chicago LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 11.1% during the third quarter. IMC Chicago LLC now owns 23,335 shares of the company's stock worth $590,000 after purchasing an additional 2,332 shares during the period. Citadel Advisors LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 234.0% during the second quarter. Citadel Advisors LLC now owns 34,972 shares of the company's stock worth $943,000 after purchasing an additional 24,501 shares during the period. Finally, UBS Group AG lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 236,300.0% during the fourth quarter. UBS Group AG now owns 2,364 shares of the company's stock worth $46,000 after purchasing an additional 2,363 shares during the period.
一些機構投資者最近增加或減少了他們在公司的股份。IMC 芝加哥有限責任公司在第三季度取消了其在普魯斯達克納斯達克生物技術的股份 11.1%。IMC 芝加哥有限責任公司現在擁有該公司股票的 23,335 股股票，價值 59 萬美元，在此期間額外購買 2,332 股股份。城堡顧問有限責任公司在第二季度取消了其在普羅斯達克納斯達克生物技術的股份 234.0%.城堡顧問有限責任公司現在擁有該公司股票 34,972 股價值 943,000 美元後，在此期間額外購買了 24,501 股。最後，瑞銀集團股份公司於第四季度取消其在普魯斯達克納斯達克生物科技股份 236,300.0% 的股份。瑞銀集團股份公司在期內額外購買 2,363 股股票後，擁有該公司股票價值 46,000 美元的 2,364 股股份。
ProShares UltraShort Nasdaq Biotechnology Stock Up 2.8 %
保碩超指數納斯達克生物科技股票上漲 2.8%
Shares of NASDAQ:BIS opened at $19.71 on Friday. The stock's 50-day moving average is $19.01 and its 200-day moving average is $21.16. ProShares UltraShort Nasdaq Biotechnology has a 52-week low of $17.88 and a 52-week high of $35.64.
納斯達克股份：國際銀行股票於週五開盤 19.71 美元。該股票的 50 日移動平均線為 19.01 美元，其 200 日移動平均線為 21.16 美元。保證超短港納斯達克生物科技有 52 周低點 17.88 美元和 52 周高點 35.64 美元。
ProShares UltraShort Nasdaq Biotechnology Company Profile
保碩超線納斯達克生物科技有限公司簡介
(Get Rating)
(取得評分)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
ProShares 超納斯達克生物科技（本基金）只尋求一天的投資業績，而不是長期投資。本基金尋求相當於指數每日表現兩倍 (200%) 的每日投資業績（扣除費用及開支前）。本基金在一個交易日以上的一段時間內的回報將是該期內每日回報加劇的結果，這很可能與該期間納斯達克生物科技指數（「指數」）的兩倍（200％）回報率不同。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- Bloomin' Brands Blossoms After Raising The Dividend
- Zebra Technologies: A Reversal Is In Play
- Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
- The S&P 500: Don't Trust The Wave Of Bullish Sentiment
- Cisco Systems Is Ready To Run Higher
- 免費索取普碩超頻納斯達克生物科技股份有限公司研究報告
- Bloomin' 品牌提高股息後綻放
- 斑馬科技：逆轉正在發揮作用
- Zoetis，寵物醫學專家，未來兩位數的盈利增長
- 標普 500：不要相信看漲情緒的浪潮
- 思科系統已準備好運作更高
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
接收普碩超頻納斯達克生物科技日報的最新消息及評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 ProShares Ultrashort 納斯達克生物技術及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。